Literature DB >> 3257254

Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983.

H A Guess1, R West, L M Strand, D Helston, E G Lydick, U Bergman, K Wolski.   

Abstract

We report a cohort study of fatal upper GI hemorrhage and/or perforation in relation to use of nonsteroidal anti-inflammatory drugs (NSAIDs) among the one million residents of Saskatchewan Canada in 1983. All hospitalized cases of GI hemorrhage and/or perforation with a fatal outcome were identified using the records linkage system of the Saskatchewan Department of Health. Discharge summaries and autopsy records were reviewed to select the cases of upper GI hemorrhage or upper GI perforation and to exclude cases in which known risk factors were present. The 134,060 residents who filled one or more prescriptions for an NSAID in 1983 were identified and individually linked to their hospital records by patient identification number. The age- and gender-specific incidence of fatal upper GI hemorrhage and/or perforation in the absence of risk factors in users was compared to that in nonusers, controlling for recent history of upper GI disease. Fatal upper GI hemorrhage or perforation in temporal association with NSAIDs is extremely rare in persons younger than 75 years of age. No temporally-related cases occurred in male NSAID users age 75 and older, but NSAID usage in this group was limited. Among women age 75 and older, the rate in users was higher than in nonusers, with the highest rate being in female NSAID users age 75 and older with a recent history of upper GI disease. Total mortality among women age 75 and older was slightly lower among users than among nonusers. Physicians who prescribe NSAIDs to patients age 75 and older should be aware of the potential risks, particularly in those with predisposing factors such as a history of upper GI disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257254     DOI: 10.1016/0895-4356(88)90007-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  27 in total

1.  Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.

Authors:  B S Bloom
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 2.  Pharmaco-epidemiological perspectives.

Authors:  U Bergman
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

Review 3.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

Review 4.  Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population.

Authors:  H G Leufkens; C B Ameling; Y A Hekster; A Bakker
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

5.  Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles.

Authors:  N S Rawson; E Malcolm; C D'Arcy
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-05       Impact factor: 4.328

Review 6.  Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.

Authors:  L B Barradell; R Whittington; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

Review 7.  Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: A conceptual framework and selected literature review.

Authors:  S E Gabriel; E L Matteson
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

8.  Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

Authors:  W E Smalley; M R Griffin; R L Fought; W A Ray
Journal:  J Gen Intern Med       Date:  1996-08       Impact factor: 5.128

Review 9.  Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach.

Authors:  F Richy; O Bruyere; O Ethgen; V Rabenda; G Bouvenot; M Audran; G Herrero-Beaumont; A Moore; R Eliakim; M Haim; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 10.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.